[go: up one dir, main page]

GR1000321B - Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως. - Google Patents

Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως.

Info

Publication number
GR1000321B
GR1000321B GR890100540A GR890100540A GR1000321B GR 1000321 B GR1000321 B GR 1000321B GR 890100540 A GR890100540 A GR 890100540A GR 890100540 A GR890100540 A GR 890100540A GR 1000321 B GR1000321 B GR 1000321B
Authority
GR
Greece
Prior art keywords
ormonic
dialy
excursion
reconstructed
proteins
Prior art date
Application number
GR890100540A
Other languages
English (en)
Other versions
GR890100540A (en
Inventor
C Scott Chappel
P Noreen Nugent
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Publication of GR890100540A publication Critical patent/GR890100540A/el
Publication of GR1000321B publication Critical patent/GR1000321B/el

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/59—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Veterinary Medicine (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Μία ανασυνδυασμένη διαλυτή πρωτεϊνη που παράγεται από την έκφραση δύο γονιδίων, που ρυθμίζονται από έναν απλό προαγωγό, που έχει σαν αποτέλεσμα να μεταβάλει την ορμονική έκκριση, όταν διοχετεύεται σε μία θεραπευτική αποτελεσματική δόση. Ενα γονίδιο κωδικοποιεί την παραγωγή μιας ισχυρά αντιγονικής, υδροφιλικής πρωτεϊνης, όπως το επιφανειακό αντιγόνο της ηπατίτιδος Β, και το άλλο γονίδιο κωδικοποιεί ένα πεπτίδιο, το οποίο μόνο του δεν είναι ουσιαστικά αντιγονικό, όπως η ορμόνη απελευθερώνουσα την ωχρινοποιητική ορμόνη.ω
GR890100540A 1988-08-30 1989-08-30 Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως. GR1000321B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US24655888A 1988-08-30 1988-08-30

Publications (2)

Publication Number Publication Date
GR890100540A GR890100540A (en) 1990-08-22
GR1000321B true GR1000321B (el) 1992-06-25

Family

ID=22931196

Family Applications (1)

Application Number Title Priority Date Filing Date
GR890100540A GR1000321B (el) 1988-08-30 1989-08-30 Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως.

Country Status (9)

Country Link
EP (1) EP0396653A1 (el)
JP (1) JPH03502584A (el)
AU (1) AU629237B2 (el)
DK (1) DK106590A (el)
FI (1) FI902151A0 (el)
GR (1) GR1000321B (el)
IL (1) IL91462A0 (el)
WO (1) WO1990002187A1 (el)
ZA (1) ZA896628B (el)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0448513A3 (en) * 1990-03-21 1991-12-27 Japat Ltd Process for production of peptidylglycine alpha-hydroxylating monooxygenase and use thereof
GB9101550D0 (en) * 1991-01-24 1991-03-06 Mastico Robert A Antigen-presenting chimaeric protein
JPH05339295A (ja) * 1991-12-05 1993-12-21 Agency Of Ind Science & Technol 抗体の作成方法
US5688506A (en) * 1994-01-27 1997-11-18 Aphton Corp. Immunogens against gonadotropin releasing hormone
ES2233284T3 (es) * 1999-02-17 2005-06-16 Pfizer Products Inc. Proteinas de fusion que comprenden portadores que pueden inducir una bdoble respuesta inmune.
EP1303533A2 (en) 2000-05-05 2003-04-23 Aphton Corporation Chimeric peptide immunogens, their preparation and use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3963691A (en) * 1974-10-07 1976-06-15 Merck & Co., Inc. Synthetic antigens of luteinizing hormone releasing hormone
GB8314362D0 (en) * 1983-05-24 1983-06-29 Celltech Ltd Polypeptide and protein products
DE3584866D1 (de) * 1984-09-12 1992-01-23 Chiron Corp Hybridpartikel-immunogene.
IL78775A (en) * 1985-05-15 1992-06-21 Biotech Australia Pty Ltd Oral vaccines
EP0224574A4 (en) * 1985-06-04 1988-04-26 Biotech Res Partners Ltd SELF-ANTIGEN VACCINES.
GB8525615D0 (en) * 1985-10-17 1985-11-20 Hoffmann La Roche Polypeptides

Also Published As

Publication number Publication date
FI902151A7 (fi) 1990-04-27
DK106590D0 (da) 1990-04-30
FI902151A0 (fi) 1990-04-27
ZA896628B (en) 1991-04-24
IL91462A0 (en) 1990-04-29
JPH03502584A (ja) 1991-06-13
GR890100540A (en) 1990-08-22
AU4076189A (en) 1990-03-23
EP0396653A1 (en) 1990-11-14
AU629237B2 (en) 1992-10-01
DK106590A (da) 1990-04-30
WO1990002187A1 (en) 1990-03-08

Similar Documents

Publication Publication Date Title
Mogensen et al. Raising antibodies to human leukocyte interferon
ES2061708T3 (es) Virus recombinante de la viruela de la gallina, vectores de expresion de proteinas heterologas y vacunas para aves de corral derivadas de este virus.
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
ES2134797T3 (es) Peptidos y fragmentos de peptidos terapeuticamente utiles.
AU1955088A (en) Avirulent microbes, incapable of producing functional adenylate cyclase and cyclic AMP
HU9500571D0 (en) Retro-, inverso-, and retro-inverso synthetic peptide analogues
PT88385A (pt) Process for preparing conjugates of citokines with immunoglobulins
GB2255093A (en) Hiv-1 core protein fragments
WO1989002277A3 (en) Prophylaxis and therapy of acquired immunodeficiency syndrome
ATE62254T1 (de) Multispezifische immunogene proteine.
ES2102347T3 (es) Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
NO167359C (no) Fremgangsmaate for fremstilling av en vaksine mot infeksjon av hepatitis b virus.
GR1000321B (el) Ανασυνδυασμενες διαλυτες πρωτεινες για την μεταβολη της ορμονικ σ εκκρισεως.
ES2144418T3 (es) Peptidos de receptores de celulas t como agentes terapeuticos para enfermedades relacionadas con el sistema inmunitario.
DE68925660D1 (de) Peptidfragmente von HIV
MY105080A (en) Heat-labile toxin b subunit fusion proteins.
ES2143996T3 (es) Antigenos peptidicos del hcv y procedimiento para la determinacion del hcv.
EP0327180A3 (en) Vaccine containing polypeptides derived from the envelope gene of human immunodeficiency virus type 1
NO942707L (no) Syntetiske peptider egnet for vaksine mot rubellsinfeksjoner
AU4803785A (en) Cross-reactive and protective epitopes of circumsporozoite proteins
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.
ES8801127A1 (es) Un procedimiento para preparar una vacuna auto antigena en forma de virus modificado de la viruela vacuna.
ATE175357T1 (de) Empfängnisverhütender impfstoff
DE68920735D1 (de) Peptide die vom Maul- und Klauenseuchevirus stammen.
OA08974A (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine